Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral L-carnitine supplementation in premature newborns
2007-002446-37Phase 3Active
- Sponsor
- CHRU Tours
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in preterm birth, sponsored by CHRU Tours. Primary endpoint: Plasma gamma-glutamyl transferase concentration after 21 days of supplementation. Started Jul 2007; status: active.
02
Drugs
levocarnitine
03
Conditions
preterm birth
Beyond the preview
Go deeper on 2007-002446-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002446-37.